• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[孕激素治疗子宫内膜异位症中的类固醇受体]

[Steroid receptors in the gestagen treatment of endometriosis].

作者信息

Seliger E, Kaltwasser P, Schneider F, Rothe K, Buchmann J

机构信息

Universitäts-Frauenklinik, Martin-Luther-Universität, Halle-Wittenberg.

出版信息

Ther Umsch. 1990 Dec;47(12):945-50.

PMID:2096479
Abstract

In 35 patients with laparoscopically proved endometriosis we determined the cytosolic estrogen and progesterone receptor content in endometrial samples before and after a 3-month course of progestagen treatment (DCC method). Dienogest was given in 20 cases, norethisterone in an other group of 15 patients. Compared with a normal group the receptor content was clearly higher in endometriosis patients. It correlated closely to the histological findings dated according to Noyes. In more than 60% of the pretherapeutic cycles there were some signs of disturbed differentiation. After 3 month of therapy the binding capacity of steroid receptors significantly decreased, particularly in norethisterone patients. Both clinical results and receptor conditions correspond to previous investigations concerning the competition behaviour, having confirmed different binding affinity to the receptor for the two gestagens here tested.

摘要

在35例经腹腔镜证实患有子宫内膜异位症的患者中,我们采用葡聚糖包被活性炭法(DCC法)测定了3个月孕激素治疗前后子宫内膜样本中细胞溶质雌激素和孕激素受体的含量。20例患者给予地诺孕素,另一组15例患者给予炔诺酮。与正常组相比,子宫内膜异位症患者的受体含量明显更高。它与根据诺伊斯标准确定的组织学结果密切相关。在超过60%的治疗前周期中存在一些分化紊乱的迹象。治疗3个月后,类固醇受体的结合能力显著下降,尤其是炔诺酮治疗的患者。临床结果和受体状况均与先前关于竞争行为的研究一致,证实了在此测试的两种孕激素对受体具有不同的结合亲和力。

相似文献

1
[Steroid receptors in the gestagen treatment of endometriosis].[孕激素治疗子宫内膜异位症中的类固醇受体]
Ther Umsch. 1990 Dec;47(12):945-50.
2
[Therapy of endometriosis with dienogest].
Zentralbl Gynakol. 1987;109(12):795-801.
3
[Behavior of parameters of liver metabolism in intermediate-term use of the gestagen dienogest in the treatment of endometriosis].[孕激素地诺孕素中期治疗子宫内膜异位症时肝脏代谢参数的变化]
Zentralbl Gynakol. 1989;111(12):807-10.
4
Dienogest, a novel synthetic steroid, overcomes hormone-dependent cancer in a different manner than progestins.地诺孕素,一种新型合成甾体,以不同于孕激素的方式攻克激素依赖性癌症。
Cancer. 1997 Jan 1;79(1):169-76.
5
Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid.新型合成类固醇地诺孕素内分泌特征的动物研究。
Drugs Exp Clin Res. 1997;23(2):45-62.
6
Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest.使用孕激素地诺孕素治疗子宫内膜异位症期间的碳水化合物代谢
Exp Clin Endocrinol. 1989 Sep;94(1-2):211-4. doi: 10.1055/s-0029-1210899.
7
Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.地诺孕素在反式激活分析中是一种选择性孕激素受体激动剂,因其有效的药代动力学特性而具有强大的口服子宫内膜活性。
Steroids. 2008 Feb;73(2):222-31. doi: 10.1016/j.steroids.2007.10.003. Epub 2007 Oct 22.
8
[Basis of gestagen therapy of endometrial carcinoma].[子宫内膜癌孕激素治疗的基础]
Dtsch Med Wochenschr. 1978 Mar 31;103(13):574-7. doi: 10.1055/s-0028-1104478.
9
Steroid receptors and endometrial cancer.
Clin Obstet Gynaecol. 1986 Dec;13(4):825-42.
10
Hormone-resistant endometriosis following total abdominal hysterectomy and bilateral salpingo-oophorectomy: correlation with histology and steroid receptor content.全腹子宫切除术和双侧输卵管卵巢切除术后激素抵抗性子宫内膜异位症:与组织学和类固醇受体含量的相关性
Obstet Gynecol. 1991 Nov;78(5 Pt 2):946-50.